Health and Fitness Health and Fitness
Tue, July 24, 2012
[ Tue, Jul 24th 2012 ] - Market Wire
Neogen reports year end results
Mon, July 23, 2012
Sun, July 22, 2012
Sat, July 21, 2012
Fri, July 20, 2012
Thu, July 19, 2012
Wed, July 18, 2012
Tue, July 17, 2012
Mon, July 16, 2012
[ Mon, Jul 16th 2012 ] - Market Wire
30 a.m. ET
Fri, July 13, 2012
Thu, July 12, 2012
Wed, July 11, 2012
Tue, July 10, 2012
Mon, July 9, 2012
Fri, July 6, 2012
Thu, July 5, 2012
Wed, July 4, 2012
[ Wed, Jul 04th 2012 ] - Market Wire
Warnex Announces Refinancing
Tue, July 3, 2012
Mon, July 2, 2012
Sun, July 1, 2012
Fri, June 29, 2012
Thu, June 28, 2012

Izard Nobel LLP Announces Class Action Lawsuit Against Centene Corporation


//health-fitness.news-articles.net/content/2012/ .. -action-lawsuit-against-centene-corporation.html
Published in Health and Fitness on Tuesday, July 10th 2012 at 13:52 GMT by Market Wire   Print publication without navigation


July 10, 2012 16:41 ET

Izard Nobel LLP Announces Class Action Lawsuit Against Centene Corporation

WEST HARTFORD, CT--(Marketwire - Jul 10, 2012) - The law firm of Izard Nobel LLP, which has significant experience representing investors in prosecuting claims of securities fraud, announces that a lawsuit seeking class action status has been filed in the United States District Court for the Eastern District of Missouri on behalf of purchasers of the common stock of Centene Corporation ("Centene" or the "Company") (NYSE: [ CNC ]) between February 7, 2012 and June 8, 2012, inclusive (the "Class Period").

The Complaint alleges that Centene and certain of its officers and directors violated the federal securities laws. Specifically, the Complaint alleges that Centene misrepresented its financial condition and failed to inform investors that the Company's 2012 outlook, provided at the start of the Class Period, lacked a reasonable basis when made due to already existing and understood competitive pressures.

On June 11, 2012, the Company's stock price plunged over 22% after the Company cut its full-year profit and revenue forecasts due to higher-than-expected medical costs. Centene revised its projections to earnings of $1.45 to $1.65 per share for 2012 versus a previous forecast of $2.64 to $2.84 per share. In addition, the Company also disclosed that expenses were above projections for commercial polices sold by its Celtic Insurance unit and Centene was evaluating goodwill and intangible assets at the unit that may result in a non-cash charge of about $28 million.

If you are a member of the class, you may, no later than August 28, 2012, request that the Court appoint you as lead plaintiff of the class. A lead plaintiff is a class member that acts on behalf of other class members in directing the litigation. Although your ability to share in any recovery is not affected by the decision whether or not to seek appointment as a lead plaintiff, lead plaintiffs make important decisions which could affect the overall recovery for class members.

While Izard Nobel LLP has not filed a lawsuit against the defendants, to view a copy of the Complaint initiating the class action or for more information about the case, and your rights, visit: [ www.izardnobel.com/centene/ ], or contact Izard Nobel LLP toll-free: (800)797-5499, or by e-mail: [ firm@izardnobel.com ]. For more information about class action cases in general, please visit our website: [ www.izardnobel.com ].



Publication Contributing Sources